| Product Code: ETC7636843 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Parkinsons Disease Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Parkinsons Disease Market - Industry Life Cycle |
3.4 Ireland Parkinsons Disease Market - Porter's Five Forces |
3.5 Ireland Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Ireland Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Ireland Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Ireland Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Ireland |
4.2.2 Technological advancements in Parkinson's disease treatment |
4.2.3 Growing awareness and early diagnosis of the disease |
4.2.4 Supportive government initiatives and funding for Parkinson's disease research and treatment |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatments |
4.3.2 Limited access to specialized healthcare services for Parkinson's patients |
4.3.3 Adverse side effects associated with certain Parkinson's disease medications |
5 Ireland Parkinsons Disease Market Trends |
6 Ireland Parkinsons Disease Market, By Types |
6.1 Ireland Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Ireland Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Ireland Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Ireland Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Ireland Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Ireland Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Ireland Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Ireland Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Ireland Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Ireland Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Ireland Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Ireland Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Ireland Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Ireland Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Ireland Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Ireland Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Ireland Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Ireland Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Ireland Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Ireland Parkinsons Disease Market Export to Major Countries |
7.2 Ireland Parkinsons Disease Market Imports from Major Countries |
8 Ireland Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis of Parkinson's disease in Ireland |
8.2 Number of Parkinson's disease clinical trials conducted in Ireland |
8.3 Percentage of Parkinson's disease patients receiving timely and appropriate treatment |
8.4 Adoption rate of new technologies in Parkinson's disease management |
8.5 Patient satisfaction with Parkinson's disease healthcare services |
9 Ireland Parkinsons Disease Market - Opportunity Assessment |
9.1 Ireland Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Ireland Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Ireland Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Ireland Parkinsons Disease Market - Competitive Landscape |
10.1 Ireland Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Ireland Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here